Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

4519

Hisse Senetlerindeki Sıralama #353
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Hisse Fiyatı
$41.34
Piyasa Değeri
$68.04B
Değişim (1 gün)
0.05%
Değişim (1 yıl)
-12.50%
Ülke
JP
Ticaret Chugai Pharmaceutical Co., Ltd. (4519)

Kategori

Healthcare
Chugai Pharmaceutical Co., Ltd. (4519) için hisse bölünme geçmişi
Chugai Pharmaceutical Co., Ltd. hissesi (sembol: 4519) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Oct 20, 2026 tarihinde gerçekleşmiştir.
Oct 20, 2026 tarihinden önce alınan bir 4519 hissesi bugün 0 4519 hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH